Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Twist Bioscience Corporation - Common Stock
(NQ:
TWST
)
52.30
-1.40 (-2.61%)
Streaming Delayed Price
Updated: 4:00 PM EST, Feb 7, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
883,068
Open
53.71
Bid (Size)
52.30 (1)
Ask (Size)
53.99 (20)
Prev. Close
53.70
Today's Range
51.04 - 54.26
52wk Range
27.41 - 60.90
Shares Outstanding
50,885,068
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Cathie Wood's Ark Invest Bets Big On Amazon, Roblox And Illumina While Trimming Palantir Stake After Alex Karp-Led Company Touched An All-Time High On Thursday
Today 5:39 EST
Ark Invest made significant trades on Friday, including buying Amazon and Roblox stock and selling Palantir stock. Other key trades were also made.
Via
Benzinga
Forecasting The Future: 6 Analyst Projections For Twist Bioscience
February 04, 2025
Via
Benzinga
Performance
YTD
+15.43%
+15.43%
1 Month
+15.91%
+15.91%
3 Month
+15.20%
+15.20%
6 Month
+18.94%
+18.94%
1 Year
+43.25%
+43.25%
More News
Read More
Twist Bioscience Announces Fiscal 2025 First Quarter Financial Results
February 03, 2025
From
Twist Bioscience Corporation
Via
Business Wire
Earnings Scheduled For February 3, 2025
February 03, 2025
Via
Benzinga
Top Wall Street Forecasters Revamp Twist Bioscience Price Expectations Ahead Of Q4 Earnings
November 18, 2024
Via
Benzinga
Twist Bioscience to Report Fiscal 2025 First Quarter Financial Results on Monday, February 3, 2025
January 22, 2025
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Present at 43rd Annual J.P. Morgan Healthcare Conference
December 19, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Cathie Wood Sees Tesla As 'Largest AI Project On Earth' — Here's Why She's Not Worried About Tech Investments
November 29, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Twist Bioscience Earnings Preview
November 15, 2024
Via
Benzinga
Deep Dive Into Twist Bioscience Stock: Analyst Perspectives (5 Ratings)
October 01, 2024
Via
Benzinga
Cathie Wood Sees $400B Opportunity In Biologics — How Have Her Bets Fared?
November 26, 2024
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
12 Health Care Stocks Moving In Monday's Pre-Market Session
November 18, 2024
Via
Benzinga
Crude Oil Rises Sharply; US Homebuilder Sentiment Surges In November
November 18, 2024
Via
Benzinga
Exposures
Fossil Fuels
Twist Bioscience's Q4 Earnings And Q1 Guidance Surpass Expectations, Stock Jumps
November 18, 2024
Via
Benzinga
Twist Bioscience Posts Upbeat Results, Joins Tesla, Amylyx Pharmaceuticals, Regenxbio And Other Big Stocks Moving Higher On Monday
November 18, 2024
Via
Benzinga
Twist Bioscience Announces Fiscal 2024 Fourth Quarter and Full Year Financial Results
November 18, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Earnings Scheduled For November 18, 2024
November 18, 2024
Via
Benzinga
Twist Bioscience to Present at 7th Annual Evercore HealthCONx Conference
November 14, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Corporation Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
November 07, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Cathie Wood's Ark Innovation, Genomic ETFs Celebrate 10 Years: How Annual Returns Stack Up Against S&P 500
October 31, 2024
Via
Benzinga
Topics
ETFs
Stocks
Exposures
US Equities
Absci and Twist Bioscience Collaborate to Design Novel Antibody using Generative AI
October 31, 2024
From
Absci Corporation
Via
GlobeNewswire
Twist Bioscience Launches FlexPrep™ Ultra-High Throughput Library Preparation Kit for Applications in Agrigenomics and Population Genomics
October 30, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience to Report Fiscal 2024 Fourth Quarter and Full Year Financial Results on Monday, November 18, 2024
October 24, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Enters into Royalty Purchase Agreement with XOMA Royalty for $15 Million in Cash
October 22, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Twist Bioscience Appoints Mike Fero, Ph.D., as Chief Information Officer
October 15, 2024
From
Twist Bioscience Corporation
Via
Business Wire
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.